Purchase Order 75N93023P01066
Award Date
8/10/23
Potential Completion Date
10/31/23
Potential Value
$24K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Novogene Corporation Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95826, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $15,900.00 contract will provide plant and animal ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) services utilizing the Illumina NovaSeq PE150 platform. The work will be performed in Sacramento, California and is expected to be...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $23,850 purchase order to Novogene Corp Inc. to provide sequencing services relating to tick studies at the Rocky Mountain Laboratories. The firm fixed price contract has a period of performance from August 16, 2023 through August 15, 2024. Novogene will perform the sequencing work at its facility in Sacramento, California to support the NIH program's...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $50,000 purchase order contract to Novogene Corp Inc. to provide next generation sequencing services relating to Ixodes scapularis ticks. The contract has a period of performance from July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contract type. Novogene will perform the sequencing work at its facility located in Sacramento, California to...
This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $27,385.82 firm fixed price delivery order to Illumina, Inc. of San Diego, California. The delivery order is for Illumina sequencing reagents to support genomic research efforts. No set-aside provisions were applied to this award placed under an existing sequencing technology contract vehicle. The contract expires on March 21, 2024 and will provide the...